Controlled Release Drug Delivery Market is projected to witness lucrative growth by reaching up to USD 101.3 billion by 2031.

Market Size
The Global Controlled Release Drug Delivery Market reached USD 50.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 101.3 billion by 2031. The global controlled release drug delivery market is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031).

Controlled release drug delivery devices hold a distinct advantage over traditional drug administration methods.

The shift in physicians' prescribing habits towards these controlled release systems, due to their high therapeutic effectiveness, enhanced patient adherence, and reduced treatment costs, is anticipated to fuel the expansion of the controlled release drug delivery market.

Moreover, the market for controlled release drug delivery is experiencing rapid growth due to several factors, including increased therapeutic effectiveness, reduced side effects, lower treatment costs, and ongoing research and development activities. The market is witnessing a surge in demand from North American regions, such as the U.S. and Canada, due to their substantial healthcare spending. Key market players include Coating Place, Inc, Corium International, Inc, Depomed, Inc, among others.

For More Insights Request Free Sample: https://www.datamintelligence.com/download-sample/controlled-release-drug-delivery-market

Controlled Release Drug Delivery Market Trends

The Growth of the Controlled Release Drug Delivery Market is Driven by the Increasing Prevalence of Chronic Diseases

The escalating incidence of chronic diseases such as diabetes, hypertension, cancer, among others, is anticipated to propel the market growth. Chronic diseases, especially obesity and diabetes, are a significant concern for the elderly population. For example, the global rise in diabetes prevalence is a key driver for market growth. The International Diabetes Federation estimates that by 2021, about 537 billion individuals, or one in every ten people globally, will have diabetes.

This number is projected to increase to 643 billion by 2030, and 783 billion by 2045. Moreover, three-quarters of individuals with diabetes reside in low- and middle-income countries. In 2021, diabetes was responsible for nearly 6.7 billion deaths worldwide, claiming one life every five seconds. The healthcare expenditure on diabetes in 2021 is expected to exceed D 966 billion, marking a 316% increase over the past 15 years. Therefore, the rise in diabetes is a significant factor driving market growth.

View Full Report: https://www.datamintelligence.com/research-report/controlled-release-drug-delivery-market

Market Segmentation

By Release Mechanism
Polymer-based drug delivery system
Activation modulated drug delivery system
Chemically activated drug delivery system

By Technology
Wurster technique
Micro encapsulation
Coacervation
Targeted delivery
Others

By Route of Administration
Drug-eluting stents
Ocular implants
Auto-injectors/ Needle-free injectors
Nasal sprays
Infusion pumps

Market Key Players
Major players are Johnson and Johnson, Coating Place, Inc, Corium International, Inc, Depomed, Inc, Pfizer, Inc, Biogen, GlaxoSmithKline, Novartis, Orbis Biosciences, Inc., Merck and Co.

Trending Reports

Liposome Drug Delivery Market - https://www.datamintelligence.com/research-report/liposome-drug-delivery-market

Intranasal Drug Delivery Market - https://www.datamintelligence.com/research-report/injectable-drug-delivery-market

Microneedles Drug Delivery Market - https://www.datamintelligence.com/research-report/microneedles-drug-delivery-market

Drug Delivery Devices Market - https://www.datamintelligence.com/research-report/drug-delivery-devices-market

Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.